Therefore, our research aims to evaluate the application value of detecting the methylation status of SEPT9, SDC2, and ALX4 genes in cell‐free DNA from CRC patients, precancerous lesion patients, and healthy individuals. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.